News from AMRI A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:AMRI)

Aug 05, 2014, 07:35 ET

AMRI Announces Second Quarter 2014 Results

 AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2014. Highlights: - Second...

Jul 22, 2014, 08:00 ET

AMRI to Announce Second Quarter Results

 AMRI (NASDAQ: AMRI) today announced it will issue second quarter financial results before the opening of the market on Tuesday, August 5,...

Jul 01, 2014, 16:05 ET

AMRI Completes Acquisition of Oso Biopharmaceuticals Manufacturing

AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Oso Biopharmaceuticals Manufacturing, a former portfolio company of...

Jun 23, 2014, 08:00 ET

AMRI Announces Early Termination of HSR Waiting Period for Acquisition of Oso Biopharmaceuticals Manufacturing

AMRI (NASDAQ: AMRI) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), in...

Jun 03, 2014, 08:00 ET

AMRI CEO to Present at the 2014 Wells Fargo Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will...

Jun 02, 2014, 08:30 ET

AMRI to Acquire Oso Biopharmaceuticals Manufacturing

 AMRI (NASDAQ: AMRI) today announced that it has signed a definitive agreement to acquire all of the outstanding membership interests of Oso...

May 19, 2014, 08:00 ET

AMRI CEO to Present at the Jefferies 2014 Global Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will...

May 07, 2014, 08:00 ET

AMRI CEO to Present at the UBS Global Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at...

May 06, 2014, 08:00 ET

AMRI Announces First Quarter 2014 Results

 AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2014. Highlights: - First...

Apr 22, 2014, 08:00 ET

AMRI to Announce First Quarter Results

AMRI (NASDAQ: AMRI) today announced it will issue first quarter financial results before the opening of the market on Tuesday, May 6, 2014. ...

Apr 16, 2014, 09:00 ET

AMRI Realigns Discovery and Development Services to Support Customer Demand

 AMRI (NASDAQ: AMRI) today announced that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y....

Apr 04, 2014, 16:05 ET

AMRI Completes Acquisition of Cedarburg Pharmaceuticals, Inc.

 AMRI (NASDAQ: AMRI) today announced that it has completed the previously announced acquisition of Cedarburg Pharmaceuticals, Inc. Cedarburg,...

Mar 26, 2014, 08:00 ET

AMRI CEO to Present at the Thirteenth Annual Needham Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at...

Mar 24, 2014, 07:00 ET

AMRI to Acquire Cedarburg Pharmaceuticals, Inc.

 AMRI (NASDAQ: AMRI) today announced that it has signed a definitive agreement to acquire all the outstanding shares of Cedarburg...

Feb 27, 2014, 08:00 ET

AMRI CEO to Present at Barclays Global Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will...

Feb 12, 2014, 08:00 ET

AMRI Announces Fourth Quarter and Full Year 2013 Results and Provides 2014 Guidance

 AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2013. Fourth...

Jan 29, 2014, 08:00 ET

AMRI to Announce Fourth Quarter and Full Year Results

AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year financial results before the opening of the market on Wednesday,...

Jan 10, 2014, 08:00 ET

AMRI Hires Vijay Kumar Batra as Managing Director, AMRI India

 Albany Molecular Research Inc. (NASDAQ: AMRI) today announced the appointment of Vijay Kumar Batra, to the position of Managing Director,...

Jan 09, 2014, 08:00 ET

AMRI CEO to Present at the 32nd Annual J.P. Morgan Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will...

Nov 20, 2013, 07:00 ET

AMRI Announces Pricing of $130 Million Cash Convertible Senior Notes

 Albany Molecular Research, Inc. (NASDAQ: AMRI) ("AMRI") announced that it has upsized to $130.0 million principal amount and priced its...